Nvidia (NASDAQ: NVDA) Stock Rating: Stop After Q3 FY1/27 Earnings
Nvidia reported $115.8 billion in Q3 revenue, up 103%, and guided $130 billion, while Jensen Huang’s resignation left Colette Kress as interim CEO.
Nvidia reported $115.8 billion in Q3 revenue, up 103%, and guided $130 billion, while Jensen Huang’s resignation left Colette Kress as interim CEO.
@akramsrazor Ultimately, over a 2 to 3 year window, there are: too many GPU/ASIC-TPU suppliers; demand is not sustainable; and there is too much price competition (in the form of loans, gaurantees, and warrants) = thus, they’re all shorts $AMD $AVGO $NVDA
Doesn’t seem like this story is going to die easily. How long until $NVDA’s GC is running the show?
To be honest though, I have successfully short $COST twice in the past, it’s just terribly low beta so even if you time it right it’s a slow trade
CNBC headline: "Nvidia interim CEO Kress talks exclusively to CNBC’s Jim Cramer". Oh no. $NVDA
Century Aluminum (CENX) could benefit from U.S. tariffs, Midwest aluminum premiums and constrained global supply, with the stock trading…
Figma grew Q3 revenue 43% to $391.4 million, raised FY2026 guidance to nearly $1.5 billion and guided Q4 above consensus despite the stock…
CDW CEO Chris Leahy says AI adoption has reached a make-or-break phase as customers seek trusted guidance amid proliferating IT choices.
Realty Income trades near $58, with 2026 AFFO guidance of $4.45 to $4.46 per share and a 5.5% dividend yield supported by a low-70% payout…
Alphabet’s Google Cloud, Gemini training costs and capex shape the company’s valuation as cloud becomes a larger earnings driver.
Perpetua Resources’ permitted Stibnite project holds 4.8 million gold ounces and a $2.9 billion EXIM loan, but faces single-asset…
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions…
Amneal Pharmaceuticals posted its fourth straight earnings beat, with Q3 revenue up 10%, raised FY26 guidance and an expanding biosimilar…
Monte Investments rotated Nvidia into Alphabet before earnings and reviews Knife River’s margin squeeze, AMD’s World Labs acquisition, and…
Elanco’s earnings inflection and prospective dividend support targeted low-double-digit EPS growth despite Zoetis discounting.
Incyte reported Q3 revenue of $1.56 billion, up 14%, as Opzelura sales rose 36%; a $1.23 billion Vega acquisition charge drove an operating…
Regeneron Q3 revenue rose 36% to $5.1 billion as Sanofi collaboration revenue jumped 68%, while EYLEA US sales fell 41%.
Sanofi Q3 sales rose 14.3% at constant currency to €14.4 billion, led by 34.8% Dupixent growth, prompting a second increase to FY26…
Transocean enters its Valaris merger with 109 of 110 available deepwater rigs contracted and 313 million shares sold short, despite weaker…
Microsoft’s Azure grew 48%, but OpenAI compute may have supplied 45% of its growth, leaving Azure excluding OpenAI up roughly 31%.
Enterprise Products Partners has pulled growth spending into 2026, while Energy Transfer’s contracted projects offer clearer EBITDA growth…
BXDC trades at a 14% discount to net liquidation value, with $1.9 billion of cash against a $1.6 billion market cap, ahead of data-center…
Amazon’s Q3 revenue reached $201.94 billion as AWS grew 39.3% to $45.98 billion and backlog hit $578 billion, supporting management’s…
Intel maintained after its post-earnings sell-off, with AI inference CPU demand and foundry customer announcements expected to drive a…
Nvidia guides for 70% growth despite supply constraints and near-100% demand, while NVDL is framed as a tactical trade amid credit, margin…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.